Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Biochimica Et Biophysica Acta|April 21, 2006
Innate immunity in amyotrophic lateral sclerosisKatie Moisse, Michael J StrongJournal of Neuroinflammation|July 9, 2008
Transient middle cerebral artery occlusion induces microglial priming in the lumbar spinal cord: a novel model of neuroinflammationKatie Moisse, Ian Welch, Tracy Hill, et al.Brain Research|July 22, 2009
Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: support for a role for TDP-43 in the physiological response to neuronal injuryKatie Moisse, Jennifer Mepham, Kathryn Volkening, et al.Brain Research|December 3, 2008
Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injuryKatie Moisse, Kathryn Volkening, Cheryl Leystra-Lantz, et al.Journal of Neuroimmunology|March 17, 2009
The complement factor C5a receptor is upregulated in NFL-/- mouse motor neuronsSaima Humayun, May Gohar, Kathryn Volkening, et al.Expert Opinion on Investigational Drugs|November 30, 2004
Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapyMichael J StrongAmyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 30, 2008
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosisMichael J StrongJournal of the Neurological Sciences|October 21, 2009
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)Michael J StrongCurrent Opinion in Neurology|September 16, 2017
Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expressionMichael J StrongPharmacology & Therapeutics|June 5, 2003
The basic aspects of therapeutics in amyotrophic lateral sclerosisMichael J StrongPageof 20